Bravecto for dogs: formulations and precautions

The duration and indications of Bravecto vary according to the formulation and parasite. The relevant official document is authoritative for each pack.

One family, several presentations

Tablets and spot-on solutions must not be merged into a single product sheet. Species, weight range, route of administration and indications must match the pack actually being considered.

Duration is not a single promise that applies to every parasite.

Use according to the package leaflet

The presentation is selected with the veterinarian or pharmacist according to the dispensing conditions. The product must not be divided, altered or combined with other treatments except as provided by the package leaflet and the professional.

Keep the packaging and official information.

Safety

Age, weight, clinical history and possible reactions must be assessed using the summary of product characteristics. If unexpected symptoms occur, contact the veterinarian without repeating the treatment independently.

Sources and document updates

This information is general and does not replace diagnosis, prescription or instructions from a veterinarian. For a medicine, the summary of product characteristics or package leaflet for the specific presentation is authoritative.

• European Medicines Agency — Bravecto - EPAR (accessed 24/07/2026)
• Union Product Database — Veterinary medicines authorised in the European Union (accessed 24/07/2026)

Editorial transparency: sources are provided to allow the documents to be checked. Professional review is only declared after genuine approval by a qualified, identifiable person.